Randall has spent more than 10 years with Titan Medical, leading the company through 30 capital transactions and raising more than $260 million to fund research and development for its surgical robotic technologies, according to a news release.
“For the past 10 years, Stephen has played a pivotal role in Titan’s journey from an early-stage startup to become a leader in single-port robotic surgical technologies,” Titan Medical CEO David McNally said in the release. “Stephen’s leadership, guidance and unwavering commitment to Titan has been vital to our business – and for that we thank him.
“I am also pleased that Stephen will remain with the company in his capacity as a director of the board and will continue to guide the company toward realizing its vision for improving patient outcomes with its single-port robotic surgical system.”
Delorme, currently VP of finance at Titan, will be promoted to the role of CFO effective Oct. 1, 2020, as part of the company’s succession plan. She had joined the company in March 2019 and worked closely with Randall during the transition period.
A veteran of more than 25 years in senior corporate leadership roles involving finance, operations, corporate strategy and change management, Delorme is a certified public accountant and has also launched a consulting practice providing financial and CFO services.
“I am excited for Monique’s promotion to CFO, having worked together with her during the transition period,” McNally said. “Her experience and leadership skills, as well as her in-depth understanding of Titan’s financial operations, made her the obvious choice as our new CFO. I welcome Monique to the executive team and look forward to her continuing contributions to Titan.”